HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
INDV
Indivior Plc
Healthcare Drug Manufacturers - Specialty & Generic ADR · United Kingdom · Reports in usd
Market Cap: $4.59B
Market Cap
$4.59B
Enterprise Val
$4.75B
P/E Ratio
21.97
P/B Ratio
-46.86
Trailing PEG (1Y)
0.05
As Of
Apr 29, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value-$99.0M
Gross Margin81.28%
Profit Margin81.28%
Return on Equity-98.70%
Return on Assets15.36%
Current Ratio0.71
Debt/Equity-3.58
LT Debt/Equity-3.18
Revenue Per Share2.87

Income Statement

Dec 31, 2025
Revenue$358.0M
Cost of Revenue$67.0M
Gross Profit$291.0M
R&D$21.0M
SG&A$189.0M
Operating Expenses$210.0M
Operating Income$81.0M
Interest Expense$6.0M
Tax Expense-$21.0M
Net Income$102.0M
EPS (Basic)$0.81
EPS (Diluted)$0.79
EBIT$87.0M
EBITDA$92.0M
Consolidated Income$102.0M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$195.0M
Accounts Receivable$253.0M
Inventory$153.0M
Current Assets$652.0M
LT Investments$28.0M
Property, Plant & Equipment$170.0M
Intangibles$2.0M
Non-Current Assets$549.0M
Total Assets$1.20B
Accounts Payable$250.0M
Current Debt$39.0M
Current Liabilities$914.0M
LT Debt$312.0M
Non-Current Liabilities$386.0M
Total Liabilities$1.30B
Total Debt$351.0M
Retained Earnings-$243.0M
Shareholder Equity-$98.0M
Shares Outstanding124,853,897

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$221.0M
Investing Cash Flow-$24.0M
Financing Cash Flow-$5.0M
CapEx-$24.0M
Free Cash Flow-$245.0M
Depreciation & Amort.$5.0M
Stock-Based Comp$5.0M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid-$5.0M
Equity Issued/Repaid$0.00
Dividends Paid$0.00
Net Change in Cash-$252.0M
Data cached · Meta live · Daily live · Statements live · TTL 24h